Over the last not even one and a half years, egg prices in the U.S. have gone through two extremes. A record high caused by highly pathogenic avian influenza (HPAI) was followed by a collapse of unprecedented scale, leading to decade-low prices today. Being now likely closer to the bottom than the top, and with odds being low that eggs are going to be given away for free, it might be a good time to have a look at this sector. Vital Farms was shining bright on the way up. Is this now an egg-citing, countercyclical opportunity?

Summary and key takeaways from today’s Weekly
– Egg prices went from record-high prices to depressed levels.
– Vital Farms was the shooting star on the way up — but it got shot down heavily.
– There are good reasons for this massive destruction of shareholder value — with maybe more to come…

Over the last not just months and quarters, but even years now, I have been very vocal about staying out of the food sector for investment purposes. Many prominent stocks are dropping like flies, repeatedly making new multi-year lows, while their dividend safety is more and more questioned.

That’s nothing new for Financial-Engineering readers.

A rare exception, and a niche where we started to get interested in, though, is the egg sector. In January, I sent to all my members my first research report for the year 2026, where I discussed the case of my favorite egg producer.

My thesis as such has not changed.

Only the price of eggs — which has fallen even further.

While my member eggs-clusive pick is holding its position strongly (+10.4% total return since my report launched), waiting for the cycle to turn, another stock has been raising one or the other eyebrow.

Vital Farms (ISIN: US92847W1036, ticker: VITL) was the seemingly unstoppable shooting star as long as egg prices kept squeezing higher. Shareholders who bought the top (or lower, but still way too early) are holding eggshells now. Since September, eight months ago, the stock collapsed by more than 80%, despite a debt-free balance sheet, and a unique strategy.

Let’s eggs-amine.

---

If you’re looking for attractive, overlooked stock ideas the majority has a blind eye on, look no further. I am offering compelling non-mainstream cases in concise 12-page member-exclusive reports.

Want to outsmart the market? Get active now! Become a supporting paid-member and receive my best stock ideas (plus updates).

The average total return of my best stock ideas is ahead of the S&P500 and the Dow Jones. With my risks-first approach (paired with high upside), I am able to find stocks with great returns.

Join me and my members on our journey to beat the markets!

^{per 12 May 2026 market close – since August 2022}

From High-flyer to … bankruptcy candidate?

Highly pathogenic avian influenza (HPAI) is a virus that comes and goes from time to time. It infects chicken and hens, leading to depopulations of nearby but-else healthy animals in order to stop further spreading.

In such a case supply is negatively affected, leading to higher egg prices.

The last round from 2024–2025 was so severe that you will not have difficulties in finding the respective period on the chart, showing U.S. egg prices over the last ten years.

No, this is not the chart of an AI stock — it’s American wholesale egg prices.

This last round led to record-high egg prices, reaching eight USD a dozen.

Note: Egg prices are per dozen, so it was c. 0.70 USD apiece at the top. Important: these are wholesale prices, not supermarket prices. In other words, prices between producers and wholesale retailers.

—

Some called this surge “egg-flation” — eggs had become horribly expensive. If they were available on the shelves at all. Over the last decade, a level of two bucks was already at the upper end of the range, so that eight was truly dramatic.

It was a big, but short-lived shock that produced what huge price spikes always do sooner or later: Demand destruction.

People bought less, while at the same time the population of egg-laying hens recovered, causing a sudden oversupply of extreme proportions. All within a few quarters, so that egg prices are now trading at the very low-end of the range of the scale.

A full dozen costs now a third of what just one egg did cost a good year ago.

Speak of dynamic times.

Theoretically, companies can choose between market-based and longer-term contract pricing. Mixes are also common, all depending on what the parties agree to, respectively what supermarkets prefer, as they want price stability, not wild fluctuation.

The higher the eggs-posure to market prices, the bigger the swings for egg producers. It takes some time until these changes reach supermarkets and thus consumers, but producing companies and their publicly traded shares react immediately in anticipation.

Which leads us to Vital Farms, the company we are looking at today.

On the way up, there were few surprises.

Egg prices up, sales up, margins up, …

… and shares up.

Concretely, between late 2023 and first mid 2024, then again into mid 2025 for an even higher high, VITL shares eggs-ploded from ten bucks to 50 USD.

Since then, however, and as egg prices did not only not recover, but fell further and continue to stay unprecedentedly low until this day, VITL stock collapsed into single-digit territory, marking new all-time lows.

note: the scale is wrong in the chart. After the “first 2024”, obviously come 2025 and 2026.

How can that be?

While the eggs-planation for the move up is easy, as a rising tide lifts all boats, the collapse cannot be explained (enough puns) simply by lower egg prices — even though this is the main driver of course.

I am saying so, because my pick for my members is holding up very well. It, too, fell from its high of last year. It would have been surprising, if it were not the case.

But, the difference is in the business models, and the balance sheets.

Unlike my pick, Vital Farms is pursuing a premium strategy, competing with green and pasture-raised eggs. There was some recent media backlash whether this is true or not (claiming green-washing), but I am not going to speculate on this one.

From a high-level view, Vital Farms’ strategy and game plan was about commanding higher prices for higher quality, and healthier eggs. And, due to the perceived competitive advantage, they claimed to be less sensitive to fluctuating egg prices — interesting.

As long as egg prices were rising, this was no big issue.

Consumers were buying, resulting in strong sales growth, driven by volumes and robust prices. However, as egg prices collapsed, the pricing gap became too big, and Vital Farms was forced to go into promotions.

Premium and promotions is a dangerous mix.

And suddenly, Vital Farms is sitting on high unsold inventory, as visible per the last results, released last week.

I mean, a rise in inventories of around 40% is brutal.

Were it for whisky bottles, okay. But eggs are quickly perishing.

So, they have only these options: selling them at aggressive discounts asap, donating, using them in the company’s cafeteria, throwing them away.

None of these options are good for the business.

One could argue that this is a one-and-done, a small bump in the road. Management on the call and in the quarterly report talked about improving business prospects and some regained volumes after they lowered prices.

The problem is, even with this move they aren’t out of the woods, yet.

The last quarter showed a net loss, and negative operating cash flow. If inventories normalize, respectively adjusted for them, OCF was a positive 10 million USD.

But VITL is investing into its infrastructure, pushing free cash flow into the red.

To remain competitive, they need to invest.

But my reading is that it is more than just about stepping back from aggressive growth, and waiting for better times from a comfortable position.

The stock would not have reacted like it has if it were the case.

Management cut Capex expectations for the year in half. On top, they announced to sell their butter business that not too long ago was presented as the second, though much smaller, leg. Of course, the official explanation is to better focus on the core egg segment.

I have my doubts, though. If everything goes so well, then a company does not suddenly part with a promising segment, nor does it a full u-turn.

A second look into the balance sheet reveals it might be a tight race for the company, if egg prices stay lower for longer. This time, I marked inventories in red, under the assumption that the accounted figure will not be realizable in the real world while simultaneously offering big promotions and facing the best-before date.

So, Vital Farms has 118 million USD in short-term liabilities to be serviced.

Not financial debt, in this regard the company is technically debt free.

But other operating expenses like supplier costs, energy, transportation, feedstock, leases, etc. still need to be paid. These 118 million USD are facing 50 million USD in real, quickly available cash. Plus another 51 million USD in receivables from customers, though we do not know when they will pay their bills. Could be tomorrow, could be in ten months.

Inventories obviously are the big wildcard.

To make it clear, I do not assume a cash crunch or collapse in the next weeks. If they sell the butter segment quickly, this would increase the cash position — even though a panic sell is unlikely to generate big proceeds.

But with real cash burn, and egg prices still dancing around 25c, while the Q1 average was at least double that number, and inflation jumping, time is not on their side.

To make matters worse, Vital Farms on the call talked about a credit line (facility) they have undrawn. Sounds good in theory, but this lifeboat would only buy time, and worse, it comes with two huge negatives. First, Vital Farms pledged practically all its assets to it, making it a slave. And second, the facility comes with strict covenants that limit the real use of it.

The up-to 60 million USD credit line require that Vital Farms does not overshoot on 3.25x net debt to EBITDA and has a minimum interest coverage ratio of 1.35x.

With business results under extreme pressure — EBITDA was just 5 million USD in Q1 2026 — there’s not much credit to borrow. Just back the envelope, on an annualized basis the 5 million USD are 20 million USD, even though this is a bit tricky as egg sales have some seasonality, with calendar quarters two and three usually being the weakest.

In other words, the 5 million USD happened in one of the stronger quarters — and as said, at about double the current egg prices on average.

Be it, even the annualized and hypothetical 20 million USD in EBITDA * 3.25x the max leverage equal almost exactly the full credit line. As the company will not aggressively max out the allowed leverage, risking the credit to be called and its assets seized, the real wiggle room is much smaller.

I haven’t done the same exercise for the interest coverage ratio, but with operating results only a smidgen above zero, it is unlikely the result will be much better.

And then there’s the thing with capital allocation.

Management aggressively poured capital into growth, while presenting high-growth targets. This has come to an end, with, as said, Capex being cut in half to preserve cash.

In the last quarter, they also — completely unnecessarily — bought back shares for 20 million USD at more than double the current price on average.

For what?

To try to appease shareholders, sure. But this was anything but wise, knowing the tough environment. Low egg prices and higher promotional activity did not occur out of nowhere.

After I have seen these things, the analysis for me was over.

Having such huge, in some parts even existential risks, I do not need to waste more time on it. The coming inflationary surge will beef up the cost basis even more, and at the same time reduce consumer budgets.

This is not an environment for me to be in.

To the contrary.

Bankruptcies do not occur suddenly. My assumption is that, if egg prices remain low, management will need to conduct a painful equity raise at these low share prices. To raise 40 million USD, which is not an extremely high figure for their business, they would need to dilute shareholders by 10–11% at the current share price.

In other words, when egg prices do not turn noticeably, and quickly so, Vital Farms will likely find itself in a tough downward spiral, destroying even more shareholder value.

Conclusion

Egg prices went from record-high prices to depressed levels.

Vital Farms was the shooting star on the way up — but it got shot down heavily.

There are good reasons for this massive destruction of shareholder value — with maybe more to come…

By becoming a Premium or Premium PLUS Member, you get instant access to all my already published research reports as well as several updates.

Likewise, you qualify for eight, respectively four more exclusive reports with my best investment ideas plus updates on the featured businesses over the next twelve months.